Journal of Infection
Volume 60, Issue 5 , Pages 403-404 , May 2010

Empiric albendazole therapy and new onset seizures – A cautionary note

,Accepted 6 February 2010.

References 

  1. Checkley AM, Chiodini PL, Dockrell DH, Bates I, Thwaites GE, Booth HL, et al. Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for investigation and initial management. J Infect. 2010;60:1–20
  2. Garcia HH, Del Brutto OH. The cysticercosis Working Group in Peru. Neurocysicercosis: updated concepts about an old diseases. Lancet Neurol. 2005;4:653–661
  3. Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004;350:249–258
  4. Proano JV, Madrazo I, Avelar F, Lopez-Felix B, Diaz G, Grijalva I. Medical treatment for neurocysticercosis characterised by giant subarachnoid cysts. N Engl J Med. 2001;345:879–885
  5. Garcia HH, Gonzalez I, Mija L. Cysticercosis Working Group in Peru. Neurocysticercosis uncovered by single-dose albendazole. N Engl J Med. 2007;356:1277–1278
  6. Flisser A, Madrazo I, Plancarte A, Schantz D, Allan J, Craig P, et al. Neurological symptoms in occult neurocysticercosis after single taenicidal dose of praziquantel. Lancet. 1993;342:748

PII: S0163-4453(10)00043-5

doi: 10.1016/j.jinf.2010.02.004

Journal of Infection
Volume 60, Issue 5 , Pages 403-404 , May 2010

Article Tools

* Image Usage & Resolution